{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:35:43Z","timestamp":1793104543748,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013465","name":"French Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["POCs(2023)-121501"],"award-info":[{"award-number":["POCs(2023)-121501"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014865","name":"Fondation Maladies Rares","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-19-CE14-0008"],"award-info":[{"award-number":["ANR-19-CE14-0008"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-18-CE18-0025-01"],"award-info":[{"award-number":["ANR-18-CE18-0025-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101564","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:46:58Z","timestamp":1755154018000},"page":"101564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"33","author":[{"given":"Ilaria","family":"Andreana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananga","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Repellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kneppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Ben Larbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Tifni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Fessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Sidi-Boumedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kryza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arpicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Gondin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Chazaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Juban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101564_bib1","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101564_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtm.2025.101564_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","article-title":"The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma","volume":"94","author":"Lapidos","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtm.2025.101564_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","article-title":"Endomysial Fibrosis in Duchenne Muscular Dystrophy: A Marker of Poor Outcome Associated With Macrophage Alternative Activation","volume":"68","author":"Desguerre","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2025.101564_bib5","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene Therapy for Duchenne Muscular Dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtm.2025.101564_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101564_bib7","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.omtm.2025.101564_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/archdischild-2015-308654","article-title":"Short stature and pubertal delay in Duchenne muscular dystrophy","volume":"101","author":"Wood","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.omtm.2025.101564_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/japplphysiol.00255.2006","article-title":"Metformin increases the PGC-1\u03b1 protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo","volume":"101","author":"Suwa","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.omtm.2025.101564_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1126\/science.aah5582","article-title":"Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy","volume":"357","author":"Myers","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101564_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211568","article-title":"Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver","volume":"14","author":"Muise","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101564_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cmet.2017.04.010","article-title":"Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice","volume":"25","author":"Cokorinos","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2025.101564_bib13","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/hmg\/ddr265","article-title":"Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle","volume":"20","author":"Ljubicic","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101564_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mus.24692","article-title":"Metformin increases peroxisome proliferator-activated receptor \u03b3 Co-activator-1\u03b1 and utrophin a expression in dystrophic skeletal muscle","volume":"52","author":"Ljubicic","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2025.101564_bib15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ajpath.2012.04.004","article-title":"AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm","volume":"181","author":"Pauly","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2025.101564_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/hmg\/ddv444","article-title":"Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles","volume":"25","author":"P\u00e9ladeau","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101564_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.642908","article-title":"Metformin Increases Sarcolemma Integrity and Ameliorates Neuromuscular Deficits in a Murine Model of Duchenne Muscular Dystrophy","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2025.101564_bib18","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201846RR","article-title":"Acute, next-generation AMPK activation initiates a disease-resistant gene expression program in dystrophic skeletal muscle","volume":"37","author":"Ng","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2025.101564_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20070075","article-title":"Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis","volume":"204","author":"Arnold","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtm.2025.101564_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/stem.1288","article-title":"Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration","volume":"31","author":"Saclier","year":"2013","journal-title":"Stem Cell."},{"key":"10.1016\/j.omtm.2025.101564_bib21","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","article-title":"Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101564_bib22","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.celrep.2018.10.077","article-title":"AMPK Activation Regulates LTBP4-Dependent TGF-\u03b21 Secretion by Pro-inflammatory Macrophages and Controls Fibrosis in Duchenne Muscular Dystrophy","volume":"25","author":"Juban","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101564_bib23","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.stemcr.2017.10.027","article-title":"Coupling between Myogenesis and Angiogenesis during Skeletal Muscle Regeneration Is Stimulated by Restorative Macrophages","volume":"9","author":"Latroche","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2025.101564_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cmet.2013.06.017","article-title":"AMPK\u03b11 Regulates Macrophage Skewing at the Time of Resolution of Inflammation during Skeletal Muscle Regeneration","volume":"18","author":"Mounier","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2025.101564_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1172\/JCI124635","article-title":"Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation","volume":"130","author":"McArthur","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101564_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202255363","article-title":"Macrophagic AMPK\u03b11 orchestrates regenerative inflammation induced by glucocorticoids","volume":"24","author":"Caratti","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omtm.2025.101564_bib27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gad.465908","article-title":"Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta\/alternative macrophage activation pathway","volume":"22","author":"Vidal","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2025.101564_bib28","doi-asserted-by":"crossref","first-page":"jcs258429","DOI":"10.1242\/jcs.258429","article-title":"Interplay between myofibers and pro-inflammatory macrophages controls muscle damage in mdx mice","volume":"134","author":"Saclier","year":"2021","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omtm.2025.101564_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99114","article-title":"PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients","volume":"3","author":"Steneberg","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.omtm.2025.101564_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S2468-1253(21)00300-9","article-title":"Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study","volume":"6","author":"Cusi","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtm.2025.101564_bib31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/biology11071041","article-title":"AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules","volume":"11","author":"Tarasiuk","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.omtm.2025.101564_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2025.101564_bib33","doi-asserted-by":"crossref","first-page":"E706","DOI":"10.1152\/ajpendo.00237.2016","article-title":"Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle","volume":"311","author":"Bultot","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2025.101564_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh3693","article-title":"Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy","volume":"7","author":"Raimondo","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101564_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12951-023-01994-0","article-title":"Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD","volume":"21","author":"Hicks","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.omtm.2025.101564_bib36","article-title":"Toxicity of gold nanoparticles (AuNPs): A review","volume":"26","author":"Sani","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.omtm.2025.101564_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113053","article-title":"Silica nanoparticles: Biomedical applications and toxicity","volume":"151","author":"Huang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtm.2025.101564_bib38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","article-title":"Advanced nanomedicines for the treatment of inflammatory diseases","volume":"157","author":"Brusini","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.omtm.2025.101564_bib39","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","article-title":"PLGA-Based Nanoparticles in Cancer Treatment","volume":"9","author":"Rezvantalab","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtm.2025.101564_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","article-title":"Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles","volume":"49","author":"Elmowafy","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.omtm.2025.101564_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70987-y","article-title":"The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy","volume":"10","author":"Hammers","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101564_bib42","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"van Putten","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2025.101564_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101564_bib44","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/pharmaceutics15061772","article-title":"Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation","volume":"15","author":"Puricelli","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omtm.2025.101564_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121919","article-title":"Nanoparticle formulation of the fusion protein virus like particles of respiratory syncytial virus stimulates enhanced in vitro antigen presentation and autophagy","volume":"623","author":"Menon","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtm.2025.101564_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jddst.2018.12.009","article-title":"Microfluidic manufacturing improves polydispersity of multicomponent polymeric nanoparticles","volume":"49","author":"Abstiens","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.omtm.2025.101564_bib47","article-title":"Microfluidic mixing system for precise PLGA-PEG nanoparticles size control","volume":"40","author":"Gimondi","year":"2022","journal-title":"Nanomedicine"},{"key":"10.1016\/j.omtm.2025.101564_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2016.01.034","article-title":"Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery","volume":"225","author":"Fonte","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtm.2025.101564_bib49","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1021\/acsnano.1c09108","article-title":"Modulating Nanoparticle Size to Understand Factors Affecting Hemostatic Efficacy and Maximize Survival in a Lethal Inferior Vena Cava Injury Model","volume":"16","author":"Hong","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.omtm.2025.101564_bib50","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/nano11030749","article-title":"PLGA Based Nanospheres as a Potent Macrophage-Specific Drug Delivery System","volume":"11","author":"Boltnarova","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.omtm.2025.101564_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43546-4","article-title":"Melatonin loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles reduce inflammation, inhibit apoptosis and protect rat\u2019s liver from the hazardous effects of CCL4","volume":"13","author":"Farid","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101564_bib52","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omtm.2025.101564_bib53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mus.23341","article-title":"A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy","volume":"45","author":"Desguerre","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2025.101564_bib54","series-title":"Skeletal Muscle Stem Cells: Methods and Protocols","first-page":"57","article-title":"Co-cultures of Macrophages with Muscle Stem Cells with Fibroadipogenic Precursor Cells from Regenerating Skeletal Muscle","author":"Panci","year":"2023"},{"key":"10.1016\/j.omtm.2025.101564_bib55","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13395-018-0186-6","article-title":"Open-CSAM, a new tool for semi-automated analysis of myofiber cross-sectional area in regenerating adult skeletal muscle","volume":"9","author":"Desgeorges","year":"2019","journal-title":"Skelet. Muscle"}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:05:27Z","timestamp":1772903127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001597"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101564","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.16.575840","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101564"}}